Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

94 5 Major Histocompatibility Complex Modulation and Loss
139 FrumentoG, FranchelloS, Palmisano
GL, Nicotra MR, Giacomini P,
Loke YW, Geragthy D, Maio M,
ManzoC, Natali PG, Ferrara GB. Tissue
Antigens 2000; 56: 30±37.
140 Polakova K, Russ G. Neoplasma 2000;
47: 342±348.
141 Wagner SN, Rebmann V,Willers CP,
Grosse-Wilde H, Goos M. Lancet
2000; 356: 220±221.
142 Trowsdale J, Ragoussis J, Campbell
RD. Immunol Today 1991; 12: 443±446.
143 Herberg JA, Sgouros J, Jones T, Copeman
J, Humphray SJ, Sheer D,
Cresswell P, Beck S, Trowsdale J. Eur
J Immunol 1998; 28: 459±467.
144 Benitez R, Godelaine D, LÕpez-Nevot
MA, Brasseur F, Jim nez P, Marchand
M, Oliva MR, van Baren N,
Cabrera T, Andry G, Landry C, Ruiz-
Cabello F, Boon T, Garrido F. Tissue
Antigens 1998; 52: 520±529.
145 Bicknell DC, Rowan A, Bodmer WF.
Proc Natl Acad Sci USA 1994; 91: 4751±
4755.
146 Browning M, Petronzelli F, Bicknell
D, Krausa P, Rowan A, Tonks S,
Murray N, Bodmer J, Bodmer W. Tissue
Antigens 1996; 47: 364±371.
147 Rosa F, Berissi H,Weinssenbach J,
Maroteaux L, Fellous M, Revel M.
EMBO J 1983; 2: 239±243.
148 Chen HL, Gabrilovich D,Virmani A
Ratnani I, Girgis KR, Nadaf-
Rahrov S, Fern—ndez-Viµa M, Carbone
P. Int J Cancer1996; 67: 756±763.
149 Real LM, Jim nez P, CantÕn J, Kirkin
A, GarcÌa A, Abril E, Zeuthen J,
Ruiz-CabelloF, GarridoF. Int J Cancer
1998; 75: 317±323.
150 M ndez R, SerranoA, Jåger E,
MalenoI, Ruiz-CabelloF, Knuth A,
GarridoF. Tissue Antigens, 2001; 57:
508±519.
151 Sanda MG, RestifoNP,Walsh JC, Kawakami
Y, Nelson WG, Pardoll DM,
Simons JW. J Natl Cancer Inst 1995; 87:
280±285.
152 RestifoNP, Esquivel F, Kawakami Y,
Yewdell JW, Mul JJ, Rosenberg SA,
Bennink JR. J Exp Med 1993; 177:
265±272.
153 Browning MJ, Krausa P, Rowan A,
Hill AB, Bicknell DC, Bodmer JG,
Bodmer WF. J Immunother 1993; 14:
163±168.
154 Hurks HM, Metzelaar-Blok JA,
Mulder A, Claas FH, Jager MJ. Int J
Cancer 2000; 85: 697±702.
155 Koopman LA, Mulder A, Corver WE,
Anholts JD, Giphart MJ, Claas FH,
Fleuren GJ. Tissue Antigens 1998; 51:
623±636.
156 Koopman LA, van der Silk AR, Giphart
MJ, Fleuren GJ. J Natl Cancer
Inst 1999; 91: 1669±1677.
157 Brady CS, Bartholomew JS, Burt DJ,
Duggan-Keen Glenville S,Telford N,
Little AM, Davidson JA, Jim nez P,
Ruiz-CabelloF, GarridoF, Stern PL.
Tissue Antigens 2000; 55: 401±411.
158 Wang Z, Marincola FM, Rivoltini L,
Parmiani G, Ferrone S. J Exp Med
1999; 190: 205±215.
159 Gattoni-Celli S, Kirsch K, Timpane
R, Isselbacher KJ. Cancer Res 1992;
52: 1201±1204.
160 Seliger B, Hohne A, Jung D, Kallfelz
M, Knuth A, Jaeger E, Bernhard
H, Momburg F, Tampe R,
Huber C. Exp Hematol 1997; 25: 608±
614.
161 Schrier PI,Versteeg R, Peltenburg
LT, Plomp AC, van't Veer LJ, Kruse-
Wolters KM. Semin Cancer Biol 1991;
2: 73±83.
162 Seliger B, Ritz U, Abele R, Bock M,
Tampe R, Sutter G, Drexler I, Huber
C, Ferrpme S. Cancer Res 2001; 24:
8647±50.
163 Qin Z, Blankenstein T. Immunity
2000; 6: 677±86.